MORGILLO, Floriana
 Distribuzione geografica
Continente #
EU - Europa 99
AS - Asia 33
NA - Nord America 31
Totale 163
Nazione #
IT - Italia 59
US - Stati Uniti d'America 31
IE - Irlanda 27
CN - Cina 10
VN - Vietnam 9
DE - Germania 3
CZ - Repubblica Ceca 2
FR - Francia 2
IN - India 2
KR - Corea 2
NL - Olanda 2
RU - Federazione Russa 2
SG - Singapore 2
SY - Repubblica araba siriana 2
TR - Turchia 2
ID - Indonesia 1
LK - Sri Lanka 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MV - Maldive 1
UA - Ucraina 1
Totale 163
Città #
Dublin 27
Caserta 16
Naples 15
Ashburn 12
Dong Ket 9
Rome 4
Wuhan 4
Bremen 3
Clarks Summit 3
Council Bluffs 3
Marano Di Napoli 3
Altavilla Silentina 2
Changsha 2
Chicago 2
Houston 2
Amsterdam 1
Andover 1
Ann Arbor 1
Beijing 1
Bitola 1
Bologna 1
Chongqing 1
Cislago 1
Dalmine 1
Dearborn 1
Denver 1
Florence 1
Goyang-si 1
Guangzhou 1
Jaipur 1
Los Angeles 1
Maharagama 1
Male 1
Milan 1
Palembang 1
Parma 1
Portici 1
Seoul 1
Shanghai 1
Vibo Valentia 1
Totale 132
Nome #
Mechanisms of resistance to EGFR-targeted drugs: lung cancer, file dfd1c04b-5e84-0799-e053-6605fe0a8ddb 30
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells, file dfd1c04b-e232-0799-e053-6605fe0a8ddb 30
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment, file dfd1c04c-1719-0799-e053-6605fe0a8ddb 20
Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence., file dfd1c04b-607b-0799-e053-6605fe0a8ddb 16
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis, file dfd1c04a-ffc4-0799-e053-6605fe0a8ddb 13
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets, file dfd1c04b-eb6a-0799-e053-6605fe0a8ddb 13
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer., file dfd1c04c-fd2d-0799-e053-6605fe0a8ddb 7
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer, file dfd1c04c-7792-0799-e053-6605fe0a8ddb 3
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells, file dfd1c04d-3444-0799-e053-6605fe0a8ddb 3
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells, file dfd1c04a-5c12-0799-e053-6605fe0a8ddb 2
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors, file dfd1c04a-6036-0799-e053-6605fe0a8ddb 2
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines, file dfd1c04a-60a4-0799-e053-6605fe0a8ddb 2
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer, file dfd1c04a-610e-0799-e053-6605fe0a8ddb 2
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors., file dfd1c04a-7045-0799-e053-6605fe0a8ddb 2
Emerging VEGF-receptor inhibitors for colorectal cancer., file dfd1c04a-70ff-0799-e053-6605fe0a8ddb 2
ONCOLOGIA MEDICA, file dfd1c04c-79e3-0799-e053-6605fe0a8ddb 2
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: A phase II study, file dfd1c04a-5e31-0799-e053-6605fe0a8ddb 1
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer., file dfd1c04a-61a4-0799-e053-6605fe0a8ddb 1
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases, file dfd1c04a-6d08-0799-e053-6605fe0a8ddb 1
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials., file dfd1c04a-6e6c-0799-e053-6605fe0a8ddb 1
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer., file dfd1c04a-6fb6-0799-e053-6605fe0a8ddb 1
The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion., file dfd1c04a-7d7d-0799-e053-6605fe0a8ddb 1
The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion., file dfd1c04a-7d7e-0799-e053-6605fe0a8ddb 1
Preoperative chemo-radiotherapy for carcinoma of the esophagus, file dfd1c04c-71fd-0799-e053-6605fe0a8ddb 1
Preoperative treatment of locally advanced esophageal carcinoma, file dfd1c04c-778c-0799-e053-6605fe0a8ddb 1
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis, file dfd1c04c-790c-0799-e053-6605fe0a8ddb 1
Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis, file dfd1c04c-79d8-0799-e053-6605fe0a8ddb 1
Nivolumab in heavily pretreated metastatic gastric cancer patients: Real-life data from a western population, file dfd1c04d-14a1-0799-e053-6605fe0a8ddb 1
Feasibility of next-generation sequencing in clinical practice: Results of a pilot study in the Department of Precision Medicine at the University of Campania ' Luigi Vanvitelli', file dfd1c04d-2d52-0799-e053-6605fe0a8ddb 1
Hypothalamic–pituitary autoimmunity in patients treated with anti-pd-1 and anti-pd-l1 antibodies, file dfd1c04d-ddbd-0799-e053-6605fe0a8ddb 1
Totale 163
Categoria #
all - tutte 764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 764


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 7 2
2019/202019 0 1 0 0 2 2 0 8 1 0 3 2
2020/202128 0 0 0 2 6 4 3 0 2 0 1 10
2021/20227 0 0 0 0 0 1 3 0 0 1 1 1
2022/202366 2 13 2 1 3 4 4 1 29 1 4 2
2023/202426 1 0 6 5 3 1 9 0 1 0 0 0
Totale 163